Biotron's Activity Report (30/7/21)
"the company progressed a lead series of compounds to preliminary safety studies and animal models of covid." "The assays were performed by collaborators at Scripps."
"The preliminary safety studies include bioavailability studies in mice and will provide key data to support their progression to testing in animal model(s) of COVID-19 infection.
The animal studies are expected to be completed in the third quarter of 2021"
Not much of the third quarter left now.
chart daily, page-1909
-
- There are more pages in this discussion • 1,385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
